Walking Fish Therapeutics rallies $73m Series A

Walking Fish Therapeutics, a provider of B cell therapeutics, has secured $73 million in Series A funding.

Walking Fish Therapeutics, a provider of B cell therapeutics, has secured $73 million in Series A funding. Northpond Ventures and First Spark Ventures led the round.

Source: Press Release